ANKRD20A3 Activators
ANKRD20A3 Activators encompass a variety of chemical compounds that engage distinct signaling pathways to indirectly bolster the functional activity of ANKRD20A3. The adenylyl cyclase activator Forskolin, and the stable cAMP analog 8-Bromoadenosine 3',5'-cyclic monophosphate, function by raising intracellular cAMP levels, thereby activating PKA which may phosphorylate and enhance the functionality of ANKRD20A3. Isoproterenol, through beta-adrenergic receptors, similarly increases cAMP and activates PKA, providing another avenue for the potential enhancement of ANKRD20A3. Activation of PKC by Phorbol 12-myristate 13-acetate could result in the phosphorylation of proteins that modulate ANKRD20A3's activity. Meanwhile, the calcium dynamics within the cell are influenced by compounds such as Ionomycin and A-23187, which by increasing intracellular calcium levels could activate calcium-dependent kinases that phosphorylate and enhance ANKRD20A3 or its associated regulatory proteins.
Additional molecules such as Okadaic acid, by inhibiting phosphatases, maintain ahigh level of protein phosphorylation that could indirectly lead to the activation of ANKRD20A3. Bisindolylmaleimide I, as a PKC inhibitor, could shift phosphorylation towards other pathways that activate ANKRD20A3, suggesting a complex interplay where inhibition in one area may lead to activation in another. Moreover, metabolic stress induced by Oligomycin might trigger alternative signaling routes that involve ANKRD20A3 activation. Thapsigargin's disruption of calcium homeostasis through inhibition of the SERCA pump may also activate pathways that enhance ANKRD20A3's activity. The inhibition of calmodulin by compounds like W-7 can influence calcium signaling, potentially upregulating alternative pathways to compensate, which could include those activating ANKRD20A3. Lastly, Zinc pyrithione's modulation of ion channels may alter signaling pathways linked to ANKRD20A3 activity, highlighting the diverse chemical toolkit that can indirectly influence the functional state of ANKRD20A3 through a range of biochemical mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylyl cyclase activator, which increases intracellular cAMP levels. Elevated cAMP activates PKA (Protein Kinase A), which can phosphorylate various target proteins, potentially including ANKRD20A3, leading to its functional enhancement. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
This cAMP analog is resistant to degradation by phosphodiesterases, thereby prolonging the activation of cAMP-dependent pathways. This can lead to sustained activation of PKA and possible subsequent phosphorylation and activation of ANKRD20A3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a non-selective beta-adrenergic receptor agonist, which can increase cAMP levels in cells. Through the same PKA-mediated mechanism as Forskolin, it may enhance the function of ANKRD20A3 by promoting phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC (Protein Kinase C) activator. PKC signaling could lead to the phosphorylation of proteins that interact with or regulate ANKRD20A3, potentially enhancing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, which could activate calcium-dependent protein kinases that may indirectly enhance ANKRD20A3 activity through phosphorylation. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin inhibitors can affect calcium signaling pathways. Disruption of calmodulin-dependent processes might increase the relative activity of other calcium-regulated proteins or pathways that could enhance the activity of ANKRD20A3. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins, which might include ANKRD20A3 or its regulatory proteins, enhancing ANKRD20A3's activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This is a selective PKC inhibitor that could shift the balance of phosphorylation towards other kinases, potentially upregulating pathways that activate ANKRD20A3. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Oligomycin is an ATP synthase inhibitor that affects cellular energy metabolism. This metabolic stress might activate compensatory signaling pathways, which could include activation of ANKRD20A3. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that disrupts calcium homeostasis in the endoplasmic reticulum, potentially affecting pathways that lead to the activation of ANKRD20A3. | ||||||